IDEXX Laboratories Inc

مادة اعلانية

Latest Update: 29 May 2026 23:59 Abu Dhabi Time.

Market Status: Closed

IDXX

IDEXX Laboratories Inc

563.16

USD

-4.870

-0.86%

Open

567.41

Prev Close

568.03

PX_VOLUME

MARKET CAP (M)

DAY RANGE

562.89 - 573.50

52 WEEKS

504.56 - 769.98

Stock Statistics

Yearly Change

9.31%

Listed Shares (Million)

108.50

Earnings Multiple

41.66

Average 30-day trading volume

536,092.14

Price-to-book ratio

28.93

Earnings Per Share

13.17

Previous Dividend Distribution

Dividend Yield

0.00%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		1,140.82	1,090.58	1,105.24	1,109.46	998.43	954.29	975.54	1,003.58	964.10	901.60	915.53
Gross Profit		722.74	658.11	683.35	694.73	623.38	570.66	596.04	619.16	593.07	526.17	547.98
Operating Income		362.59	315.60	354.85	373.05	316.53	261.69	303.89	263.80	298.96	245.30	275.28
Net Income		278.45	248.19	274.61	293.99	242.68	216.15	232.84	203.30	235.58	194.52	212.23
Profit Margin		24.41	22.76	24.85	26.50	24.31	22.65	23.87	20.26	24.44	21.58	23.18

	Period Ending:	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Revenue		4,303.70	3,897.50	3,660.95	3,367.32	3,215.36	2,706.66
Gross Profit		2,659.58	2,378.93	2,189.97	2,004.34	1,889.43	1,571.04
Operating Income		1,364.23	1,132.84	1,098.23	902.16	934.13	695.12
Net Income		1,059.46	887.87	845.04	679.09	744.84	582.13
Profit Margin		24.62	22.78	23.08	20.17	23.17	21.51

Balance Sheet

	Period Ending:	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		3,385.50	3,350.76	3,386.71	3,330.79	3,213.69	3,293.44	3,350.77	3,414.87	3,353.52	3,259.92	3,086.40
Total Liabilities		1,829.39	1,745.38	1,825.53	1,871.97	1,765.68	1,698.13	1,732.71	1,834.61	1,784.61	1,775.40	1,789.00
Total Equity		1,556.10	1,605.38	1,561.19	1,458.83	1,448.01	1,595.31	1,618.05	1,580.25	1,568.91	1,484.53	1,297.41

	Period Ending:	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Assets		3,350.76	3,293.44	3,259.92	2,746.76	2,437.20	2,294.56
Total Liabilities		1,745.38	1,698.13	1,775.40	2,138.03	1,747.21	1,661.77
Total Equity		1,605.38	1,595.31	1,484.53	608.74	689.99	632.80

Cash Flows Statements

	Period Ending:	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Cash From Operating Activities		266.25	355.76	402.34	185.74	237.96	262.02	220.08	248.31	198.58	249.85	272.43
Cash From Investing Activities		-33.54	-28.13	-44.87	-33.63	-29.61	-39.84	-27.37	-32.91	-106.94	-30.44	-27.84
Cash From Financing Activities		-211.43	-355.70	-313.31	-165.63	-330.32	-232.78	-290.98	-210.24	-144.07	-101.84	-43.04
Net Change in Cash		20.46	-28.10	43.57	0.62	-124.30	-20.37	-92.95	4.16	-56.50	122.24	198.86

	Period Ending:	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash From Operating Activities		1,181.80	929.00	906.51	542.98	755.55	648.06
Cash From Investing Activities		-136.24	-207.06	-125.25	-195.35	-292.97	-109.38
Cash From Financing Activities		-1,164.96	-878.07	-442.00	-370.94	-697.41	-248.42
Net Change in Cash		-108.20	-165.67	341.39	-31.91	-239.47	293.60

* In Million of United States Dollar

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.

IDXX

IDEXX Laboratories Inc